LeMaitre Vascular PE Ratio 2010-2023 | LMAT
Current and historical p/e ratio for LeMaitre Vascular (LMAT) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. LeMaitre Vascular PE ratio as of April 23, 2024 is 46.50.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
LeMaitre Vascular PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-23 | 64.23 | 47.93 | |
2023-12-31 | 56.62 | $1.34 | 42.26 |
2023-09-30 | 54.20 | $1.21 | 44.80 |
2023-06-30 | 66.77 | $1.13 | 59.09 |
2023-03-31 | 50.97 | $0.93 | 54.81 |
2022-12-31 | 45.44 | $0.93 | 48.86 |
2022-09-30 | 49.91 | $0.96 | 51.99 |
2022-06-30 | 44.75 | $1.01 | 44.30 |
2022-03-31 | 45.52 | $1.25 | 36.41 |
2021-12-31 | 49.07 | $1.26 | 38.94 |
2021-09-30 | 51.75 | $1.32 | 39.21 |
2021-06-30 | 59.36 | $1.39 | 42.71 |
2021-03-31 | 47.35 | $1.16 | 40.82 |
2020-12-31 | 39.22 | $1.04 | 37.71 |
2020-09-30 | 31.42 | $0.93 | 33.79 |
2020-06-30 | 25.42 | $0.81 | 31.39 |
2020-03-31 | 23.91 | $0.87 | 27.48 |
2019-12-31 | 34.38 | $0.88 | 39.06 |
2019-09-30 | 32.60 | $0.95 | 34.32 |
2019-06-30 | 26.62 | $0.91 | 29.25 |
2019-03-31 | 29.40 | $1.11 | 26.48 |
2018-12-31 | 22.36 | $1.13 | 19.78 |
2018-09-30 | 36.54 | $1.04 | 35.14 |
2018-06-30 | 31.52 | $1.08 | 29.19 |
2018-03-31 | 34.04 | $0.88 | 38.68 |
2017-12-31 | 29.86 | $0.85 | 35.13 |
2017-09-30 | 35.04 | $0.77 | 45.50 |
2017-06-30 | 29.18 | $0.69 | 42.30 |
2017-03-31 | 22.98 | $0.60 | 38.30 |
2016-12-31 | 23.59 | $0.55 | 42.89 |
2016-09-30 | 18.44 | $0.55 | 33.52 |
2016-06-30 | 13.23 | $0.49 | 26.99 |
2016-03-31 | 14.34 | $0.45 | 31.87 |
2015-12-31 | 15.89 | $0.42 | 37.82 |
2015-09-30 | 11.19 | $0.40 | 27.99 |
2015-06-30 | 11.04 | $0.34 | 32.48 |
2015-03-31 | 7.64 | $0.32 | 23.89 |
2014-12-31 | 6.94 | $0.23 | 30.19 |
2014-09-30 | 6.21 | $0.17 | 36.55 |
2014-06-30 | 7.43 | $0.17 | 43.73 |
2014-03-31 | 7.22 | $0.15 | 48.15 |
2013-12-31 | 7.14 | $0.21 | 33.99 |
2013-09-30 | 5.95 | $0.20 | 29.74 |
2013-06-30 | 5.78 | $0.19 | 30.43 |
2013-03-31 | 5.45 | $0.18 | 30.30 |
2012-12-31 | 5.02 | $0.15 | 33.50 |
2012-09-30 | 5.60 | $0.13 | 43.06 |
2012-06-30 | 5.21 | $0.17 | 30.65 |
2012-03-31 | 5.09 | $0.15 | 33.94 |
2011-12-31 | 5.09 | $0.13 | 39.18 |
2011-09-30 | 5.33 | $0.24 | 22.22 |
2011-06-30 | 6.04 | $0.25 | 24.17 |
2011-03-31 | 5.80 | $0.31 | 18.72 |
2010-12-31 | 5.75 | $0.37 | 15.55 |
2010-09-30 | 5.99 | $0.32 | 18.72 |
2010-06-30 | 4.76 | $0.31 | 15.35 |
2010-03-31 | 3.82 | $0.28 | 13.66 |
2009-12-31 | 4.25 | $0.10 | 42.48 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.409B | $0.193B |
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
Stryker (SYK) | United States | $124.672B | 30.91 |
Medtronic (MDT) | Ireland | $106.983B | 15.15 |
Boston Scientific (BSX) | United States | $99.792B | 33.18 |
EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
ResMed (RMD) | United States | $26.527B | 26.52 |
Terumo (TRUMY) | Japan | $25.252B | 35.66 |
Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
Baxter (BAX) | United States | $20.516B | 14.96 |
Koninklijke Philips (PHG) | Netherlands | $19.139B | 15.27 |
Insulet (PODD) | United States | $11.513B | 60.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
Demant (WILYY) | Denmark | $9.853B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.989B | 23.80 |
BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
Haemonetics (HAE) | United States | $4.247B | 21.72 |
Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
Envista Holdings (NVST) | United States | $3.456B | 13.14 |
QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
Neogen (NEOG) | United States | $2.552B | 24.54 |
Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
ICU Medical (ICUI) | United States | $2.348B | 17.52 |
TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
Owens & Minor (OMI) | United States | $1.856B | 17.82 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
InMode (INMD) | Israel | $1.439B | 7.45 |
AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
Warby Parker (WRBY) | United States | $1.218B | 0.00 |
AtriCure (ATRC) | United States | $1.099B | 0.00 |
MacroGenics (MGNX) | United States | $0.964B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
Evolus (EOLS) | United States | $0.679B | 0.00 |
Quanterix (QTRX) | United States | $0.623B | 0.00 |
Valneva SE (VALN) | France | $0.552B | 0.00 |
Jin Medical (ZJYL) | China | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
PetIQ (PETQ) | United States | $0.486B | 18.14 |
TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
ZimVie (ZIMV) | United States | $0.422B | 25.82 |
Biote (BTMD) | United States | $0.414B | 3.94 |
OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
Surmodics (SRDX) | United States | $0.361B | 39.06 |
Zynex (ZYXI) | United States | $0.358B | 41.26 |
Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
Cerus (CERS) | United States | $0.306B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.178B | 0.00 |
High Tide (HITI) | Canada | $0.171B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
Fonar (FONR) | United States | $0.103B | 8.80 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
Chimerix (CMRX) | United States | $0.082B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Safety Shot (SHOT) | United States | $0.077B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.52 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |